Ameresco, Inc.

AMRC

CIK 0001488139 · Quarterly mode · latest period FY2025 (Q3) (ending 2025-09-30) · sourced from SEC EDGAR

At a glance · FY2025 (Q3)

Revenue
$526M
↑+5.0% +$25Mvs FY2024 (Q3)
Operating Income
$42M
↑+20.5% +$7Mvs FY2024 (Q3)
Net Income
$14M
↑+39.7% +$4Mvs FY2024 (Q3)
Gross Profit
$84M
↑+9.3% +$7Mvs FY2024 (Q3)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Weak
43/100
  • Profitability
    31ROIC 11.2% (10% = solid, 20%+ = moat)
  • Liquidity
    48Current Ratio 1.46 (above 1.5 = solid)
  • Leverage
    60D/E 0.80 (under 0.5 = conservative)
  • Efficiency
    19Asset Turnover 0.45x (1.0+ = capital-efficient)
  • Growth
    33Revenue YoY +5.0% (10% = solid, 25%+ = elite)
  • Margin Trend
    67Op Margin 8.1% · trend +1.0pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project AMRC's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

8%

Trailing CAGR unavailable; default 8%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$36.68
Total enterprise IV
$1.95B
Diluted shares
0.05B
Terminal PV
$1.41B (72% of total)
Year-5 FCF
$166M
YearProjected FCFDiscounted PV
+1$122M$111M
+2$132M$109M
+3$143M$107M
+4$154M$105M
+5$166M$103M
Terminal$2.28B$1.41B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$2M
investment in PP&E
Stock buybacks (TTM)
share count reduction
Stock-based comp (TTM)
$14M
non-cash dilution

Balance sheet · 2025-09-30

latest filed snapshot
Total assets
$4.43B
everything owned
Total liabilities
$261M
everything owed
Stockholders' equity
$1.06B
shareholder claim
Net debt
$249M
LT debt minus cash

Recent performance · 64 quarters

Revenue↑+5.0% +$25M
$526M
Net Income↑+5.3% +$933K
$19M
Free Cash Flow↓-26.5% -$6M
$18M
Operating Margin↑+1.0pts
8.1%

Drill down